These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24468867)

  • 1. Performance of the Abbott RealTime HIV-1 assay versus the roche amplicor HIV-1 MonitorTM Test, v1.5, UltraSensitive assay for samples with low plasma HIV-1 RNA copy numbers.
    Stephan C; Hill A; Hadacek MB; van Delft Y; Moecklinghoff C
    J Antimicrob Chemother; 2014 Jun; 69(6):1708-10. PubMed ID: 24468867
    [No Abstract]   [Full Text] [Related]  

  • 2. Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals.
    Taylor N; Schmid I; Egle A; Greil R; Patsch W; Oberkofler H
    Antivir Ther; 2009; 14(8):1189-93. PubMed ID: 20032549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing diagnostic cut-off criteria for the COBAS AmpliPrep/COBAS TaqMan HIV-1 Qualitative test through validation against the Amplicor DNA test v1.5 for infant diagnosis using dried blood spots.
    Maritz J; Preiser W; van Zyl GU
    J Clin Virol; 2012 Feb; 53(2):106-9. PubMed ID: 22196872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High correlation between the Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes.
    Karasi JC; Dziezuk F; Quennery L; Förster S; Reischl U; Colucci G; Schoener D; Seguin-Devaux C; Schmit JC
    J Clin Virol; 2011 Nov; 52(3):181-6. PubMed ID: 21813320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of versions 1.0 AND 1.5 of the UltraSensitive AMPLICOR HIV-1 MONITOR test for subjects with low viral load.
    Jackson JB; Piwowar-Manning E; Johnson-Lewis L; Bassett R; Demeter LM; Brambilla D
    J Clin Microbiol; 2004 Jun; 42(6):2774-6. PubMed ID: 15184467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative performance of the new Aptima HIV-1 Quant Dx assay with three commercial PCR-based HIV-1 RNA quantitation assays.
    Hopkins M; Hau S; Tiernan C; Papadimitropoulos A; Chawla A; Beloukas A; Geretti AM
    J Clin Virol; 2015 Aug; 69():56-62. PubMed ID: 26209380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of performance across the dynamic range of the Abbott RealTime HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses.
    Swanson P; Huang S; Abravaya K; de Mendoza C; Soriano V; Devare SG; Hackett J
    J Virol Methods; 2007 Apr; 141(1):49-57. PubMed ID: 17184853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays--LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 Monitor v1.5.
    Katsoulidou A; Petrodaskalaki M; Sypsa V; Papachristou E; Anastassopoulou CG; Gargalianos P; Karafoulidou A; Lazanas M; Kordossis T; Andoniadou A; Hatzakis A
    J Virol Methods; 2006 Feb; 131(2):168-74. PubMed ID: 16194575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.
    Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
    J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multisite comparison of reproducibility and recovery from the standard and ultrasensitive Roche AMPLICOR HIV-1 MONITOR assays.
    Brambilla DJ; Granger S; Jennings C; Bremer JW
    J Clin Microbiol; 2001 Mar; 39(3):1121-3. PubMed ID: 11230438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the NucliSens EasyQ HIV-1 v1.1 and RealTime HIV-1 kits for quantitation of HIV-1 RNA in plasma.
    Choi JY; Kim EJ; Rho HJ; Kim JY; Kwon OK; Lee JH; Koo MJ; Kim SS
    J Virol Methods; 2009 Oct; 161(1):7-11. PubMed ID: 19576640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardization and performance evaluation of "modified" and "ultrasensitive" versions of the Abbott RealTime HIV-1 assay, adapted to quantify minimal residual viremia.
    Amendola A; Bloisi M; Marsella P; Sabatini R; Bibbò A; Angeletti C; Capobianchi MR
    J Clin Virol; 2011 Sep; 52(1):17-22. PubMed ID: 21764631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from London: comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx HIV RNA Quantitative assays.
    Swanson P; Holzmayer V; Huang S; Hay P; Adebiyi A; Rice P; Abravaya K; Thamm S; Devare SG; Hackett J
    J Virol Methods; 2006 Nov; 137(2):184-92. PubMed ID: 16876263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance evaluation of the COBAS/TaqMan HIV-1 v2.0 in HIV-1 positive patients with low viral load: a comparative study.
    Paba P; Fabeni L; Ciccozzi M; Perno CF; Ciotti M
    J Virol Methods; 2011 May; 173(2):399-402. PubMed ID: 21419171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the analytical performance of the new Abbott RealTime RT-PCRs for the quantitative detection of HCV and HIV-1 RNA.
    Schutten M; Fries E; Burghoorn-Maas C; Niesters HG
    J Clin Virol; 2007 Oct; 40(2):99-104. PubMed ID: 17768084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Abbott m2000rt RealTime HIV-1 assay with manual sample preparation compared with the ROCHE COBAS AmpliPrep/AMPLICOR HIV-1 MONITOR v1.5 using specimens from East Africa.
    Crump JA; Scott LE; Msuya E; Morrissey AB; Kimaro EE; Shao JF; Stevens WS
    J Virol Methods; 2009 Dec; 162(1-2):218-22. PubMed ID: 19729037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing HIV viral load assays and frequency of low level virological rebound in clinical practice.
    Briggs R; Templeton K; Fernando I
    Int J STD AIDS; 2014 Dec; 25(14):1029-34. PubMed ID: 24648315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Generic HIV Viral Load assay with the Amplicor HIV-1 monitor v1.5 and Nuclisens HIV-1 EasyQ v1.2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: the Kesho Bora preparatory study.
    Rouet F; Foulongne V; Viljoen J; Steegen K; Becquart P; Valéa D; Danaviah S; Segondy M; Verhofstede C; Van de Perre P;
    J Virol Methods; 2010 Feb; 163(2):253-7. PubMed ID: 19837114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 (CAP/CTM v2.0) with other real-time PCR assays in HIV-1 monitoring and follow-up of low-level viral loads.
    Wojewoda CM; Spahlinger T; Harmon ML; Schnellinger B; Li Q; Dejelo C; Schmotzer C; Zhou L
    J Virol Methods; 2013 Jan; 187(1):1-5. PubMed ID: 23098667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of elevated HIV-1 viral load results obtained from samples stored frozen in vacutainer plasma preparation tubes.
    Cloherty G; Swanson P; Lucic D; Dieckhaus K; Anthony P; Cataline P; Herman C; Hackett J; Skolnik PR; Chirch L
    J Virol Methods; 2014 Aug; 204():91-2. PubMed ID: 24747107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.